Ascendis Pharma A/SASNDNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+41.8%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+41.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$15.32M+216.3%
2024$4.84M-33.7%
2023$7.30M+35.8%
2022$5.38M+1565.1%
2021$-367000.00-67.6%
2020$-219000.00+6.4%
2019$-234000.00+40.6%
2018$-394000.00+17.4%
2017$-477000.00-110.1%
2016$-227000.00-